| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| C4 Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 35,500 | 18 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CCCC | C4 Therapeutics, Inc. | 18 Jun 2025 | 1 | $0 | 4 | Director | 20 Jun 2025, 16:11 |
| ARTV | Artiva Biotherapeutics, Inc. | 18 Jul 2024 | 0 | $0 | 3 | Director | 18 Jul 2024, 20:02 |
| CCCC | C4 Therapeutics, Inc. | 20 Jun 2024 | 1 | $0 | 4 | Director | 21 Jun 2024, 16:08 |
| CCCC | C4 Therapeutics, Inc. | 15 Jun 2023 | 1 | $0 | 4 | Director | 16 Jun 2023, 16:24 |
| CCCC | C4 Therapeutics, Inc. | 29 Jul 2022 | 1 | $0 | 4 | Director | 02 Aug 2022, 16:23 |
| CCCC | C4 Therapeutics, Inc. | 29 Jul 2022 | 0 | $0 | 3 | Director | 02 Aug 2022, 16:18 |